Matches 1 - 36 out of 36


Match Document Document Title
DE102006035020B4 Stabilization of NAD / NADH  
A test element for the determination of an analyte comprising (i) a coenzyme dependent enzyme or a substrate for such an enzyme and (ii) as a coenzyme a compound having the following general...
DE20122767U1 Massive parallel method for decoding DNA and RNA  
On Nucleotide analogue which comprises: a) a base selected from the group consisting of adenine or an analogue of adenine, Cytosine or an analogue of cytosine, guanine or an analogue of Guanine,...
DE102005035461A1 Stable NAD / NADH derivatives  
The Invention relates to stable nicotinamide adenine dinucleotide (NAD / NADH) - or nicotinamide adenine dinucleotide phosphate (NADP / NADPH) derivatives, Enzyme complexes of these derivatives...
DE102006035020A1 Test element for determining analytes, comprises stabilized coenzyme and coenzyme-dependent enzyme, used especially for determination of glucose  
A test element (A) for determination of an analyte comprises: (i) a coenzyme-dependent enzyme (E) or a substrate for E; and (ii) as a coenzyme, a stabilized NAD derivative (I), or its salts or...
DE102006012317A1 New macromolecular compounds comprising nucleotide and nucleoside building blocks, are useful in enzymatic reactions and nucleic acid analysis  
Macromolecular compounds (I) are new. Macromolecular compounds (I) of formula (Nuc-linker) n-marker, are new. Nuc : nucleotide or nucleoside; linker : a linker component, the Nuc components and...
DE102004063339A1 Probe for detecting nucleic acids  
The Invention relates to a probe for detecting nucleic acids, method for the preparation of the probe, methods of making a detection reactions and test kits that contain those reagents necessary...
DE102004056980A1 A method for site-specific synthesis of biopolymers on solid supports  
The Invention relates to methods for site-specific synthesis of biopolymers such as nucleic acids or peptides, and their respective derivatives on solid supports, wherein the local Discrimination...
DE10120798B4 A method for determining the gene expression  
process for the analysis of gene expression in which single gene providing one the gene products with a uniform or several different primers in the form of gene primer hybridization products on a...
DE10152147A1 Process for applying nucleosides and / or nucleotides to functionalized surfaces and process for determining coupling yields in the synthesis of nucleotides  
The present invention relates to a method for applying nucleosides and / or nucleotides to functionalized surfaces which are provided with reactive functional groups, the reactive functional...
DE10120798A1 A method for determining the gene expression  
The invention relates to a method for the analysis of gene expression, that is, for parallel analysis of the expression of a large number of genes. The method is based on the analysis of sequences...
DE10027821A1 New intermediate in isoprenoid biosynthesis, useful in screening for potential herbicides, comprises mutant encoding-enzymes sequences for imparting herbicide resistance  
Intermediate (A), optionally isotopically labeled, in the mevalonate-independent pathway of isoprenoid biosynthesis, is new. Independent claims are also included for the following: (a) aqueous...
DE10024314A1 Regeneration of NAD(P)H from NAD(P)+ formed in an oxidative enzymatic reaction comprises indirect electrochemical reduction  
NAD(P)H is regenerated by electrochemical reduction from NAD(P)<+> formed in an oxidative enzymatic reaction of an oxidizable substrate in the presence of NAD(P)H. Regeneration of NAD(P)H from...
DE10011480A1 Nucleic acid for amplifying and quantitatively and qualitatively detecting aquaporin genes, gene fragments, RNA or expression of an aquaporin gene from Vitis species  
A nucleic acid (N1) for amplifying and quantitatively and qualitatively detecting aquaporin genes, RNA or gene expression, is new. N1 is a nucleic acid or its complement, reverse, reverse...
DE10011400A1 Targeted photolytic deprotection of nucleoside derivatives, useful for synthesis of DNA chips, includes coating with a gel or viscous liquid before illumination  
Targeted photolytic cleavage of protecting groups from a nucleoside derivative (I), immobilized on a carrier, comprising applying a layer of gel or viscous liquid (A) to immobilized (I) and...
DE19855963A1 Amphiphilic glyceryl, processes for their preparation and their use  
The invention relates to glyceryl nucleotides of formula (Ia), wherein a) one of the radicals A<1>, A<2> and A<3> represents a hydrogen atom, or a radical selected among hydroxyl, mecapto, alkyl,...
DE19850433A1 New coenzyme A derivatives useful for the synthesis of L(-)-carnitine and gamma-butyrobetaine  
Crotonobetainyl-coenzyme A and psi -butyrobetainyl-coenzyme A as characterized by various physical properties are claimed as well as their use in the activation of L-(-)-carnitine dehydratase, the...
DE19850426A1 New gamma-butyrobetainyl-coenzyme A, useful for activating L(-)-carnitine dehydratase, especially for preparing L(-)-carnitine from crotonobetaine  
psi -Butyrobetainyl-coenzyme A (I) is new. psi -Butyrobetainyl-coenzyme A (I) having the following characteristics is new: molecular weight 895.2; absorption maxima at 206 and 258 nm; molar...
DE19848403A1 Exponential amplification of molecular matrices, useful for chemical evolution of e.g. peptides or nucleic acids, by synthesizing copies of immobilized matrices  
A method for exponential amplification of molecular matrices (MM) is new and comprises: (1) binding MM to the surface of a solid phase via a reversible linker; (2) adding matrix fragments (MF),...
DE19750508A1 New phospholipid-nucleoside adducts useful for treating and preventing mammary tumors and leukemia  
Phospholipid-nucleoside adducts (I) are new. Phospholipid-nucleoside adducts of formula (I) are new. R = 4-22C hydrocarbon group which is saturated or unsaturated and may be substituted by one or...
DE19627032A1 Non-radioactively labelling nucleoside-3'-phosphate  
Preparation of a non-radioactively labelled nucleoside-3'-phosphate (I), from a nucleoside-3'-phosphate (II) containing a nucleo-base, a pentose and a phosphate group, comprises: (a) coupling (II)...
DE19543493A1 The stabilized coenzyme solutions and their use for the determination of dehydrogenases or their substrates in an alkaline medium  
The invention relates to stabilised coenzyme solutions which contain up to approximately 60mM of a heavy metal salt and optionally a complexing agent in a defined ratio with the heavy metal salt....
DE19509038A1 C-nucleoside derivatives and their use in the detection of nucleic acids  
The invention concerns pyrrolo-[3, 2-d]pyrimidine, pyrazolo-[4, 3-d]pyrimidine and pyrimidine-furanosides, i.e. so-called C-nucleosides of general formulae (I) - (V), and corresponding derivatives...
DE19505168A1 Specific lipid conjugates of nucleoside diphosphonates and their use as medicaments  
The invention pertains to novel phospholipid derivatives of nucleosides of the general formula (I), wherein R<1> is an optionally mono- or polysubstituted, straight-chain or branched, saturated or...
DE4418690A1 Nucleoside 5'-mono-phosphate ester(s) of glyceryl di:ether derivs.  
Nucleoside 5'-monophosphate esters of glyceryl diether derivs. of formula (I), their salts, tautomers, optically active forms, and racemic mixts., are new: R1 = 1-20C satd. or unsatd. alkyl chain,...
DE4239815A1 Improved B¶1¶¶2¶ conjugates  
For the preparation of cobalamin conjugates of the formula (I) ## STR5 ## where B is the residue formed from a cobalamin by cleavage of a -CONH ↓ 2 ↓ group, $ AP is the coupling partner of the...
DE4232899A1 NADH and NADPH as a medicament for the treatment of Alzheimer's disease  
Use of the reduced form of nicotinamide adenine dinucleotide (NADH), the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) or a physiologically acceptable salt thereof for the...
DE4128625A1 DRUG AGAINST CANCER AND AIDS  
Use of nicotinamide adenine dinucleotide (NADH), nicotinamide adenine dinucleotide phosphate (NADPH) or a physiologically acceptable salt thereof for the treatment of cancer and AIDS.
DE4102817A1 METHOD FOR PRODUCING STEREOSELECTIVE (BETA) -FUCOPYRANOSYL-PHOSPHATES AND VERY PURE GDP FUCOSE  
The invention relates to a process for the stereoselective preparation of β-L-fucopyranosyl-phosphates via the trichloroacetimidates of the protected L-fucose and the synthesis and purification of...
DE4100361C1 Use of NADH and NADPH for the treatment of depression  
Use of nicotinamide adenine dinucleotide (NADH), nicotinamide adenine dinucleotide phosphate (NADPH) or a physiologically acceptable salt thereof for the treatment of depression.
DE4102240C1 Use of NADH and NADPH for energy substitution in the human body  
Use of nicotinamide adenine dinucleotide in its reduced form (NADH) and / or nicotinamide adenine dinucleotide phosphate in its reduced form (NADPH) and / or a physiologically acceptable salt...
DE3936802A1 High mol. wt. forms of amine-contg. coenzyme prodn. - by reacting coenzyme with bis:oxiranyl cpd. and macro:molecule, giving regeneratable prods. for use in continuous enzymatic processes  
Prodn. of functional coenzymes (A), contg. amino-N and having increased mol. wt., comprises (1) reacting (A) with excess of a bisoxiranyl cpd. (C), then (2) reacting the prod. with a...
DE3141030C2 Crystalline β-nicotinamide adenine dinucleotide tetrahydrate and methods of making the same and the high purity amorphous product  
Described are new highly pure and stable crystals of β-nicotinamide adenine dinucleotide tetrahydrate (NAD) in the triclinic system with a space group of P l or Pl and lattice constants: A = 8.861...
DE3543347C2 Process for the preparation of nucleoside derivatives  
The present invention relates to a novel process for the preparation of nucleoside derivatives of the general formula I $ F1 wherein B is adenine, cytosine, 5-fluorouracil, 5-aza cytosine,...
DE3809024A1 Composition for the treatment of Parkinson's syndrome  
Use of the enzyme cofactor NADH or of a salt thereof for the production of a pharmaceutical composition suitable for the treatment of Parkinson's syndrome.
DE3807003A1 Composition for treating Parkinson's syndrome  
Use of the enzyme cofactor NAD or of a salt thereof for producing a pharmaceutical composition suitable for the treatment of Parkinson's syndrome.
DE3728772A1 ENZYME REACTOR WITH cofactor on a polymer  
Process for the binding of cofactors to polymers, in which an aromatic or benzylic amino group-carrying cofactor is first converted into the corresponding isothiocyanate and then attached to a...

Matches 1 - 36 out of 36